Supernus Pharmaceuticals | SUPN - Capital Social e Reservas





Capital Social e Reservas Alterar Data
Abbott USD 52.06B 69M 2026-03
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 697.59M 60.58M 2026-03
Cara Therapeutics USD 14.5M 6.44M 2026-03
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Eisai JPY 906.56B 7.57B 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Novo Nordisk DKK 221.28B 18.21B 2026-06
Pacira USD 671.98M 18.08M 2026-06
Perrigo USD 2.52B 17M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Xeris Pharmaceuticals USD -9.73M 22.74M 2026-06